For laboratory research use only. Not for human consumption.

Timeline8 milestones

BPC-157 Research Timeline

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide originally derived from a protein found in human gastric juice. Since its initial characterization in the early 1990s, researchers have studied this compound extensively in preclinical models, producing a substantial body of literature focused on tissue repair mechanisms, angiogenesis, and cytoprotection.

1991–1993

Discovery and initial characterization

Researchers at the University of Zagreb identified BPC-157 as a stable fragment of a larger protein found in human gastric juice. Early studies by Sikiric et al. established the compound's stability in acidic environments and began documenting its effects in gastrointestinal injury models.

J Pharmacol Exp Ther

1997

Tendon and ligament research begins

A study published in the Journal of Orthopaedic Research examined BPC-157 in a rat Achilles tendon transection model. Researchers reported improved biomechanical properties and increased collagen organization in treated groups compared to controls.

J Orthop Res

1999

Gastrointestinal cytoprotection studies expand

Multiple publications explored BPC-157's effects on experimentally induced gastric ulcers, intestinal anastomosis healing, and inflammatory bowel models. Researchers documented accelerated mucosal healing and reduced lesion size across several rodent models.

J Physiol Paris

2003

Detailed Achilles tendon repair study

Staresinic et al. published a study examining transected rat Achilles tendons. The research documented improved biomechanical outcomes, functional indices, and collagen formation in BPC-157 treated groups, significantly expanding interest in musculoskeletal applications.

J Orthop Res · PMID: 14554208

2010–2011

Growth factor receptor research

Chang et al. published findings showing that BPC-157 dose- and time-dependently increased growth hormone receptor expression in tendon fibroblasts. A follow-up study demonstrated enhanced tendon explant outgrowth and increased cell survival under oxidative stress conditions.

J Appl Physiol · PMID: 21030672

2018

Nitric oxide system interactions documented

Research teams explored BPC-157's relationship with the nitric oxide (NO) system, including interactions with NO synthase pathways. These studies positioned BPC-157 within a broader signaling framework involving vascular function and tissue remodeling.

Curr Pharm Des

2021–2023

Angiogenesis and pathway signaling research

Several publications examined BPC-157's effects on angiogenesis-related pathways, including VEGF expression and FAK-paxillin signaling. Researchers began mapping the compound's influence on cell migration and vascular formation in preclinical models.

2025

Systematic review of 36 studies

Vasireddi et al. published a systematic review in the Orthopaedic Journal of Sports Medicine analyzing 36 studies from 1993 to 2024. The review documented BPC-157's effects on growth hormone receptor expression and multiple pathways involved in cell growth and angiogenesis across preclinical models.

Orthop J Sports Med · PMID: 40756949

Why This Research Matters

The research trajectory of BPC-157 shows a clear progression from basic gastrointestinal studies to a broader understanding of tissue repair mechanisms. Over three decades, published research has expanded from simple cytoprotection models to complex pathway analyses involving growth factor receptors, angiogenesis, and nitric oxide signaling. The 2025 systematic review represents an important milestone — consolidating findings from dozens of studies into a structured framework that informs future preclinical research directions.

Research Use Compliance

All information presented in this article references published research literature and is intended for educational purposes only. Research peptides are sold strictly for laboratory research use and are not approved for human consumption or medical treatment.